(Q40893414)

24 September 2017

1 reference

title

Mechanisms of proteinuria in noninflammatory glomerular diseases (English)

1 reference

24 September 2017

Savin VJ

1

1 reference

24 September 2017

1 April 1993

1 reference

American Journal of Kidney Diseases

24 September 2017

1 reference

24 September 2017

21

1 reference

24 September 2017

4

1 reference

24 September 2017

347-362

1 reference

24 September 2017

The nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Management of nephrotic syndrome in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Paucity of minimal-change lesion in children with early frequently relapsing steroid-responsive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Treatment of proteinuric idiopathic glomerulonephritides in adults: a retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Serum IgE in patients with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Serum IgE in primary glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Pathogenesis of lipoid nephrosis: a disorder of T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Nephrotic syndrome associated with T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The immune system in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Putative N-terminal sequence of murine soluble immune response suppressor (SIRS): significant homology with short neurotoxin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Effect of prednisone on nephrotic peripheral blood mononuclear cell mediated increase in 35sulfate uptake in rat glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

A highly cationic protein in plasma and urine of children with steroid-responsive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The vascular permeability factor is a T lymphocyte product

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

A glomerular permeability factor produced by human T cell hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Epidemiology of idiopathic glomerular disease: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Epidemiologic survey of children with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrence of idiopathic nephrotic syndrome after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrent focal sclerosis after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrence of nephrotic syndrome during cyclosporin treatment after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Ciclosporin-induced partial and transient improvement of nephrotic syndrome in recurrent focal segmental glomerulosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Plasma exchange for recurrent nephrotic syndrome following renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Recurrent focal glomerulosclerosis: natural history and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glomerular lesions in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Renal complications in patients with the acquired immune deficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Human immunodeficiency virus (HIV) infection and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Absence of HIV antigens in renal tissue from patients with HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

HIV-associated nephropathy in transgenic mice expressing HIV-1 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

A review of transcapillary fluid and solute exchange in the renal glomerulus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Anionic sites and the mechanisms of proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Concentration polarization in an ultrafiltering capillary

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Distribution of endogenous albumin in the rat glomerulus: role of hemodynamic factors in glomerular barrier function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Functional and structural alterations of the glomerular permeability barrier in experimental galactosemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glycosaminoglycan synthesis by glomeruli in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Scanning electron microscopy of the kidney glomerular epithelium after treatment with polycations in situ and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glomerular epithelial alterations resulting from sialic acid surface coat removal

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Xylosylated-proteoglycan-induced Golgi alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Porous substructure of the glomerular slit diaphragm in the rat and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Acute reversible proteinuria induced by infusion of the polycation hexadimethrine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glomerular charge and urinary protein excretion: effects of systemic and intrarenal polycation infusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Size and charge selective permeability defects induced in glomerular basement membrane by a polycation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Steroid-responsive nephrotic syndrome: a generalised disorder of membrane negative charge

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Ultrastructural alterations in the sialic acid distribution in minimal change disease and membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Basement membrane charge in human glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Alterations in the extracellular matrix components in human glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The Nature of the Glomerular Injury in Minimal Change and Focal Sclerosing Glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Altered glomerular permeability as a result of focal detachment of the visceral epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The permeability of glomerular capillaries of aminonuceoside nephrotic rats to graded dextrans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glomerular permeability and polyanion in adriamycin nephrosis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Unaltered anionic sites of glomerular basement membrane in aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Status of glomerular proteoglycans in aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Anionic site and immunogold quantitation of heparan sulfate proteoglycans in glomerular basement membranes of puromycin aminonucleoside nephrotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Maleic vinyl ether anhydride nephropathy: altered glomerular permeability due to an immunomodulating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Immunopathogenesis of crescentic glomerulonephritis and lung purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Rapid and focal loss of negative charge associated with mononuclear cell infiltration early in nephrotoxic serum nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Induction of proteinuria in the rat by a monoclonal antibody against SGP-115/107

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Epitope specific induction of proteinuria by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Quantitative studies of monoclonal antibody 5-1-6-induced proteinuric state in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

The role of reactive oxygen species in animal models of glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

A role for oxygen free radicals in aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Effect of indomethacin on glomerular permeability in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Reduction of proteinuria by indomethacin in patients with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Treatment of the nephrotic syndrome with indomethacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Reversible renal failure and nephrotic syndrome without interstitial nephritis from zomepirac

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Platelet-activating factor-induced loss of glomerular anionic charges

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980260-5

7 January 2021

10.1016/S0272-6386(12)80260-5

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8465812